ABPI President Steps Down Amid Novo Nordisk Code Of Practice Breach
Executive Summary
The president of the Association of the British Pharmaceutical Industry and UK head of Novo Nordisk, Pinder Sahota, has resigned from the role at the association after the company breached the ABPI Code of Practice.
You may also be interested in...
Canadian HTA Ups Industry Fees To Fund Review Process Improvements
Canada’s health technology appraisal body is to increase its industry fees well beyond inflation for conducting reviews and scientific advice. It says it will also improve its drug reimbursement review process.
Saudi Regulator Becomes First Arab Member Of PIC/S
Saudi Arabia’s medicines agency says its membership of the international Pharmaceutical Inspection Co-operation Scheme will contribute to developing and raising inspectors' efficiency.
France Trials Quicker Route To Patients For Innovative Medicines
France is piloting a new approach that will allow innovative products to be accessed by patients before a reimbursement price has been agreed.